ElmerGW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
JAMA.
1996;275:870-876.
McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract.
FEMS Immunol Med Microbiol.
1993;6:251-264.
Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing
Lactobacillus acidophilus
as prophylaxis for candidal vaginitis.
Ann Intern Med.
1992;116:353-357.
Friedlander A, Druker MM, Schachter A.
Lactobacillus acidophillus
and vitamin B complex in the treatment of vaginal infection.
Panminerva Med.
1986;28:51-53.
Hilton E, Rindos P, Isenberg HD.
Lactobacillus
GG vaginal supositories and vaginitis [letter].
J Clin Microbiol.
1995;33:1433.
Reid G, Bruce AW, McGroarty JA, et al. Is there a role for lactobacilli in prevention of urogenital and intestinal infections.
Clin Microbiol Rev.
1990;3:335-344.
Williams LR, Home VN, Zhang X, et al. The composition and bactericidal activity of oil of
Melaleuca alternifolia
(tea tree oil).
Int J Aromather.
1989;1:15-17.
Hammer KA, Carson CF, Riley TV. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to
Melaleuca alternifolia
(tea tree) oil [letter].
Antimicrob Agents Chemother.
1999;43:196.
Pea EF.
Melaleuca alternifolia
oil. Its use for trichomonal vaginitis and other vaginal infections.
Obstet Gynecol.
1962;19:793-795.
Lippert U, Walter A, Hausen B, et al. Increasing incidence of contact dermatitis to tea tree oil [abstract].
J Allergy Clin Immunol.
2000;105(1 pt 2):A127.
van Slyke KK, Michel VP, Rein MF. Treatment of vulvovaginal candidiasis with boric acid powder.
Am J Obstet Gynecol.
1981;141:145-148.
Jovanovic R, Congema E, Nguyen HT. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis.
J Reprod Med.
1991;36:593-597.
Penna RP, Corrigan LL, Welsh J, et al.
Handbook of Nonprescription Drugs.
6th ed. Washington, DC: American Pharmaceutical Association; 1979:424.
Giron LM, Aguilar GA, Caceres A, et al. Anticandidal activity of plants used for the treatment of vaginitis in Guatemala and clinical trial of a
Solanum nigrescens
preparation.
J Ethnopharmacol.
1988;22:307-313.
Zawadzki J, Suchy H, Scheller S. Use of propolis for treatment of vaginitis and cervicitis [in Polish; English abstract].
Przegl Lek.
1973;30:620-623.
Guiraud P, Steiman R, Campos-Takaki GM, et al. Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone.
Planta Med.
1994;60:373-374.
Sandhu, D.K. Warraich, MK Singh S. Sensitivity of yeast isolated from cases of vaginitis to aqueous extracts of garlic.
Mykosen.
1981;23:691-698.
Ghannoum MA. Studies on the anticandidal mode of action of
Allium sativum
(garlic).
J Gen Microbiol.
1988;134:2917-2924.
Hughes BG, Lawson LD. Antimicrobial effects of
Allium sativum
L. (garlic),
Alliumampeloprasum
L. (elephant garlic), and
Allium cepa
L. (onion), garlic compounds and commercial garlic supplement products.
Phytother Res.
1991;5:154-158.
Kaneda Y, Torii M, Tanaka T, et al. In vitro effects of berberine sulphate on the growth and structure of
Entamoeba histolytica,
Giardia lamblia
and
Trichomonas vaginalis.
Ann Trop Med Parasitol.
1991;85:417-425.
Pattnaik S, Subramanyam VR, Bapaji M, et al. Antibacterial and antifungal activity of aromatic constituents of essential oils.
Microbios.
1997;89:39-46.
Quale JM, Landman D, Zaman MM, et al. In vitro activity of
Cinnamomum zeylanicum
against azole resistant and sensitive Candida speces and a pilot study of cinnamon for oral candidiasis.
Am J Chin Med.
1996;24:103-109.
Singh HB, Srivastava M, Singh AB, et al. Cinnamon bark oil, a potent fungitoxicant against fungi causing respiratory tract mycoses.
Allergy.
1995;50:995-999.
Reid G, Charbonneau D, Erb J, et al. Oral use of
Lactobacillus rhamnosus
GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
FEMS Immunol Med Microbiol.
2003;35:131-134.
Jeavons HS. Prevention and treatment of vulvovaginal candidiasis using exogenous
Lactobacillus.
J Obstet Gynecol Neonatal Nurs.
2003;32:287-296.
Pirotta M, Gunn J, Chondros P, et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial.
BMJ.
2004;329:548.
Petersen EE, Magnani P. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis; a randomised, double blind, placebo-controlled study.
Eur J Obstet Gynecol Reprod Biol.
2004;117:70-75.
Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with
bacterial vaginosis.
Clin Microbiol Infect.
2007;13:657-664.
Larsson PG, Stray-Pedersen B, Ryttig KR, et al. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
BMC Womens Health.
2008 Jan 15.
Barrons R, Tassone D. Use of
Lactobacillus
probiotics for bacterial genitourinary infections in women: A review.
Clin Ther.
2008;30:453-468.
Petricevic L, Witt A. The role of L
actobacillus casei rhamnosus
Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis.
BJOG.
2008;115:1369-1374.
Ya W, Reifer C, Miller LE.
Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study.
Am J Obstet Gynecol.
2010;203(2):120.e1-6.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.